UnitedHealthcare · Cochlear Implant Unilateral · US health-plan appeal rights

Cochlear Implant Unilateral denied as duplicate or overlapping therapy by UnitedHealthcare?

Q: How long do I have to appeal a UnitedHealthcare Cochlear Implant Unilateral denial?

Internal appeal window: Typically 180 days from the denial date. External review window: Typically 60–120 days after the final internal denial. The clock starts from the date on the denial letter.

If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.

By Michael John Ryan, Founder & Privacy Officer, DenialHelp, LLC

Last reviewed 2026-05-11

Policy data current as of 2026-04-26

US health-plan appeal rights

Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules

Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.

Internal appeal window

Typically 180 days from the denial date

External review window

Typically 60–120 days after the final internal denial

What UnitedHealthcare typically requires

UnitedHealthcare's specific coverage criteria for cochlear implant unilateral are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

Source policy: UHC Medical Policy: Cochlear Implants and Auditory Brainstem Implants + Hearing Aids/BAHA

The UnitedHealthcare angle on Cochlear Implant Unilateral

## Why UnitedHealthcare Issues a Duplicate-Therapy Denial for Unilateral Cochlear Implants

A duplicate-therapy denial from UnitedHealthcare typically means the plan has identified that the patient already has an existing cochlear implant system — either from a prior authorization on record or from a prior claim — and is treating the new request as duplicating coverage already provided. This can also occur when a claim for a cochlear implant is submitted alongside, or shortly after, a claim for hearing aids or audiological rehabilitation, and the claims system flags them as overlapping therapies for the same condition.

In practice, this denial often reflects an administrative or claims-processing error rather than a genuine clinical policy decision. A request for a replacement processor, a system upgrade, or the second implant in a sequential bilateral program is clinically distinct from the original implant and is not a duplicate.

## Why This Denial Is Appealable

Duplicate-therapy denials are frequently overturned when the clinical record clearly distinguishes the current request from the previously covered service. If the request is for a replacement component, a device upgrade, or rehabilitation following the implant (rather than another implant), the plan must recognize those as separate, clinically necessary services.

## Your Federal Appeal Rights

Internal appeal: Provide a clear written explanation of how the requested service differs from the prior service identified as a duplicate. Include dates, device identifiers, and clinical purpose for each service.
Expedited review: If the patient is currently without a functioning device and delay causes meaningful harm, request expedited internal review (72-hour response required in most cases).
External review (ACA §2719): Available once internal appeals are exhausted. An independent reviewer can confirm that the services are clinically distinct.
ERISA §503: For employer-sponsored plans, you are entitled to all documents and criteria used in reaching the duplicate-therapy determination.
Timeline: Internal appeal: consult your denial letter for the filing deadline (commonly 180 days). External review: generally available within four months of final internal denial.

## Documentation to Gather

Itemized description of the current request: A precise description of what is being requested — including device model, component type, and whether it is a new implant, replacement processor, upgrade, or separate ear — clearly differentiated from any prior authorized service.
Prior authorization / claims history: Obtain a record of what UHC previously authorized or paid for this patient, so the appeal can specifically identify what is and is not duplicated.
Prescriber letter: A letter from the implanting surgeon or audiologist explaining why the current request is clinically distinct from any prior service and why it is independently medically necessary.
Device or component condition records: If the request involves a damaged, failed, or technologically outdated component, documentation of the existing device's condition supports the case that replacement is not a duplicate.

## Criteria-Mapping Structure

Obtain UHC's coverage policy for cochlear implants and the plan's definition of duplicate therapy. Then map the distinction:

| Prior Service (the alleged duplicate) | Current Request (the distinct service) | |---|---| | [Date, device, ear, clinical purpose of prior service] | [Date, device, ear, clinical purpose of current request] |

Make the distinction as explicit and factual as possible. The reviewer must be able to see at a glance that these are not the same service.

Next steps

Find the date on the denial letter — your appeal window starts there.
Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
Request the insurer's claim file in writing — they must provide it.
Submit your appeal in writing with new clinical evidence and a physician statement.

Get the letter drafted

DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.

Start my appeal — $30 with code SEO25 →

Related appeal guides

Other UnitedHealthcare appeals

Other denial reasons for UnitedHealthcare Cochlear Implant Unilateral

denied as not medically necessary denied for failing step therapy denied as non-formulary denied for missing prior authorization denied as experimental or investigational

This guide describes general US federal appeal rights based on Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules. Your specific plan documents (Summary of Benefits and Coverage, Evidence of Coverage) override anything here. DenialHelp is not your lawyer and not your physician — we draft appeal letters that your physician signs. Outcomes depend on your insurer's decision and factors outside our control. Reviewed by Michael John Ryan on 2026-05-11. Editorial standards: denialhelp.com/authors.